279 related articles for article (PubMed ID: 30029699)
1. In
Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
[TBL] [Abstract][Full Text] [Related]
2. Cell therapy to remove excess copper in Wilson's disease.
Gupta S
Ann N Y Acad Sci; 2014 May; 1315(1):70-80. PubMed ID: 24820353
[TBL] [Abstract][Full Text] [Related]
3. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
4. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
[TBL] [Abstract][Full Text] [Related]
5. The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease.
Allen KJ; Cheah DM; Lee XL; Pettigrew-Buck NE; Vadolas J; Mercer JF; Ioannou PA; Williamson R
Cell Transplant; 2004; 13(7-8):765-73. PubMed ID: 15690978
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein is elevated in liver and duodenum of Atp7b
Zhang CC; Volkmann M; Tuma S; Stremmel W; Merle U
Biometals; 2018 Aug; 31(4):617-625. PubMed ID: 29732486
[TBL] [Abstract][Full Text] [Related]
7. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease.
Park SM; Vo K; Lallier M; Cloutier AS; Brochu P; Alvarez F; Martin SR
Cell Transplant; 2006; 15(1):13-22. PubMed ID: 16700326
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of ATP7B-transduced bone marrow mesenchymal stem cells decreases copper overload in rats.
Chen S; Shao C; Dong T; Chai H; Xiong X; Sun D; Zhang L; Yu Y; Wang P; Cheng F
PLoS One; 2014; 9(11):e111425. PubMed ID: 25375371
[TBL] [Abstract][Full Text] [Related]
10. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease.
Irani AN; Malhi H; Slehria S; Gorla GR; Volenberg I; Schilsky ML; Gupta S
Mol Ther; 2001 Mar; 3(3):302-9. PubMed ID: 11273771
[TBL] [Abstract][Full Text] [Related]
11. Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
Overeem AW; Klappe K; Parisi S; Klöters-Planchy P; Mataković L; du Teil Espina M; Drouin CA; Weiss KH; van IJzendoorn SCD
J Hepatol; 2019 Aug; 71(2):344-356. PubMed ID: 30965071
[TBL] [Abstract][Full Text] [Related]
12. Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease.
Malhi H; Irani AN; Volenberg I; Schilsky ML; Gupta S
Gastroenterology; 2002 Feb; 122(2):438-47. PubMed ID: 11832458
[TBL] [Abstract][Full Text] [Related]
13. Toxic milk mice models of Wilson's disease.
Hadrian K; Przybyłkowski A
Mol Biol Rep; 2021 Feb; 48(2):1903-1914. PubMed ID: 33590415
[TBL] [Abstract][Full Text] [Related]
14. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease.
Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F
Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson's disease.
Fujiyoshi J; Yamaza H; Sonoda S; Yuniartha R; Ihara K; Nonaka K; Taguchi T; Ohga S; Yamaza T
Sci Rep; 2019 Feb; 9(1):1535. PubMed ID: 30733544
[TBL] [Abstract][Full Text] [Related]
16. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin.
Zhang S; Chen S; Li W; Guo X; Zhao P; Xu J; Chen Y; Pan Q; Liu X; Zychlinski D; Lu H; Tortorella MD; Schambach A; Wang Y; Pei D; Esteban MA
Hum Mol Genet; 2011 Aug; 20(16):3176-87. PubMed ID: 21593220
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
[TBL] [Abstract][Full Text] [Related]
18. Metabolic dysregulation in the
Wooton-Kee CR; Robertson M; Zhou Y; Dong B; Sun Z; Kim KH; Liu H; Xu Y; Putluri N; Saha P; Coarfa C; Moore DD; Nuotio-Antar AM
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2076-2083. PubMed ID: 31924743
[TBL] [Abstract][Full Text] [Related]
19. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
